Consequently, adipose inflammation and obesity are remarkably diminished by all kinds of SSAO inhibitors in obese and diabetic rodent models (Supplementary Table 1) (Papukashvili et al., 2020). The gene discussed is AOC3; the disease is obesity due to melanocortin 4 receptor deficiency.